Skip to main content

Peer Review reports

From: Worse prognosis of KRASc.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)

Original Submission
29 Sep 2012 Submitted Original manuscript
29 Sep 2012 Author responded Author comments - Enrico Ricevuto
Resubmission - Version 2
29 Sep 2012 Submitted Manuscript version 2
5 Nov 2012 Reviewed Reviewer Report - raffaele palmirotta
10 Nov 2012 Reviewed Reviewer Report - Takayuki Yoshino
5 Dec 2012 Reviewed Reviewer Report - Paolo Correale
14 Dec 2012 Author responded Author comments - Enrico Ricevuto
Resubmission - Version 3
14 Dec 2012 Submitted Manuscript version 3
12 Jan 2013 Author responded Author comments - Enrico Ricevuto
Resubmission - Version 4
12 Jan 2013 Submitted Manuscript version 4
Publishing
4 Mar 2013 Editorially accepted
4 Mar 2013 Article published 10.1186/1741-7015-11-59

You can find further information about peer review here.

Back to article page